Ultimele actualizari :
29/10/2024
Citostatic   Nivolumab  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Opdivo Argentina, Belgia, Brazilia, Chilli, Elvetia, Finlanda, Franta, Germania, Irlanda, Italia, Japonia, Luxemburg, Marea Britanie, Mexic, Norvegia, Peru, Romania, Slovenia, Spania, Suedia, Ungaria
Bibliografie   Injectabil   Bibliografie : Nivolumab  
tip publicare
2296 Laborator Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
4025 poster Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M.
Stabilité physico-chimique de solutions de Nivolumab à 1 mois.
SFPO Congress 2017 - Nantes 2017
4505 ziar Le Guyader G, Vieillard V, Mouraud S, Do B, Marabelle A, Paul M.
Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion.
Eur J Cancer 2020 ; 135: 192-202.
4652 Laborator Nivolumab (Opdivo®) - Summary of Product Characteristics
Bristol Myers Squibb Pharmaceuticals 2022

  Mentions Légales